Condition: HIV · Cervical Cancer · Sponsor: University of California, San Diego
While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for HIV care and treatment programs in Nigeria to integrate cervical cancer screening and treatment and conduct a cluster randomized, hybrid type III trial design to assess the comparative effectiveness of a Core set of implementation strategies versus a Core+ (enhanced) set of implementation strategies to implement cervical cancer screening, onsite treatment, referral and referral completion, treatment, and retention in care among WLHIV. The overarching goal is to improve the health and life expectancy of WLHIV with co-occurring cervical cancer.
This description comes directly from the study's public registry record.
Gregory Aarons, PhD · 858-966-7703 · gaarons@health.ucsd.edu
Echezona Ezeanolue, MD, MPH · +234 803 773 9972 · echezona.ezeanolue@unn.edu.ng
Always discuss trial participation with your own doctor first.
| UC San Diego | La Jolla, California, United States | Recruiting |
| University of Nigeria, Nsukka | Enugu, Enugu State, Nigeria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06128304